Table 1 Positivity of biological markers of congenital toxoplasmosis in infected newborns from mothers treated with spiramycin (Group 1) and from untreated mothers (Group 2)
| Â | Group 1 | Group 2 | pa | ||
|---|---|---|---|---|---|
Infected (N = 27) | Infected (N = 19) | ||||
| Â | n% Sensibility (%) | n% Sensibility (%) | Â | ||
PCR | 1 (3,70) | 3,7 | 6 (31,58) | 31,58 | 0,053 |
Positive | |||||
Negative | 26 (96,30) | Â | 13 (68,42) | Â | Â |
IgM | 7 (25,93) | 25,93 | 13 (68,42) | 68,42 | 0,0662 |
Positive | |||||
Negative | 20 (74,07) | Â | 6 (31,58) | Â | Â |
IgA | 3 (11,11) | 11,11 | 7 (36,84) | 36,84 | 0,0969 |
Positive | |||||
Negative | 24 (88,89) | Â | 12 (63,16) | Â | Â |